FOLD Financial Facts
Loss from operations: -44.94MInterest income: 460K
See Full Income Statement
Other non-current assets: 1.79M
Total stockholders' equity: 336.56M
See Full Balance Sheet
Amicus Therapeutics, Inc. (FOLD) Earnings
|
Expand Research on FOLD
| Next EPS Date | 5/7/24 | EPS Growth Rate | +66.7% |
|---|---|---|---|
| Average EPS % Beat Rate | +16.1% | Revenue Growth Rate | +30.2% |
| Average % Move 1-Wk after EPS | -4.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/5/18 |  |
Q318 | -$0.84 | -$0.28 | -$0.56 | $20.6M | $23.57M | = |  | | Details |
2/14/11  |
|
Q410 | -$0.48 | -$0.15 | -$0.33 | $922K | $9M | N/A | | | Details |
| 5/8/19 | |
Q119 | -$0.56 | -$0.31 | -$0.25 | $34M | $37.86M | = | | | Details |
| 5/5/15 |
|
Q115 | -$0.35 | -$0.21 | -$0.14 | N/A | $250K | N/A | | | Details |
| 11/8/17 | |
Q317 | -$0.41 | -$0.31 | -$0.10 | $10.9M | $9.52M | = | | | Details |
| 11/5/12 |
|
Q312 | -$0.31 | -$0.24 | -$0.07 | $5.8M | $8.82M | N/A | | | Details |
| 8/9/16 | Q216 | -$0.40 | -$0.33 | -$0.07 | N/A | $170K | N/A | | | Details | |
| 3/3/15 |
|
Q414 | -$0.24 | -$0.18 | -$0.06 | N/A | $390K | N/A | | | Details |
